SEBI has completed Recovery Certificate No. 4355 of 2021 issued against Venmax Drugs and Pharmaceuticals Limited (PAN: AAACY1073C), signifying successful conclusion of the recovery proceedings.
Impact
Low
Severity
Low
Justification
Administrative closure of a recovery certificate against a single defaulting entity. No market-wide regulatory changes or new compliance requirements introduced. Impact is limited to the specific defaulter.
BSE announces Demat Auction for Settlement No. 825 dated February 23, 2026, covering 103 scrips where shares were not delivered in demat form by sellers.
Impact
Medium
Severity
Medium
Justification
Routine demat auction notice affecting 103 scrips across diverse sectors. Large quantities in a few scrips (NOVARTIS 4031, BGIL FILMS 3602, MRC AGROTECH 3000) may indicate settlement stress for those counters; overall market impact is limited.